Keyphrases
Brain Tumor
100%
Indoleamine 2,3-dioxygenase 1 (IDO1)
100%
Regulatory T Cells
100%
Treg
52%
Glioma
23%
Tumor
11%
Glioblastoma multiforme
11%
Survival Benefit
11%
Long-term Survival
11%
Gene-deficient Mice
11%
Orthotopic Model
5%
Transgenic Mice
5%
Immunosuppression
5%
Tumor-promoting
5%
Expression Level
5%
T Cells
5%
Preclinical Data
5%
Clinical Significance
5%
Clinical Data
5%
Transgenic Mouse Model
5%
Poor Prognosis
5%
CD4+
5%
Patient Survival
5%
Adult Brain Tumors
5%
T-cell Mediated
5%
Tumor Rejection
5%
Glioma Model
5%
Better Prognosis
5%
FoxP3+
5%
Medicine and Dentistry
Intracranial Tumor
100%
Indoleamine 2,3 Dioxygenase
100%
Regulatory T Cell
100%
Ganglioglioma
29%
Neoplasm
17%
Glioblastoma
11%
Long Term Survival
11%
T Cell
11%
Immunosuppressive Drug
11%
Immunosuppressive Treatment
5%
Transgenic Mouse
5%
Tumor Rejection
5%
Pharmacology, Toxicology and Pharmaceutical Science
Indoleamine 2,3 Dioxygenase
100%
Intracranial Tumor
100%
Neoplasm
23%
Glioblastoma
11%
Immunosuppressive Agent
11%
Long Term Survival
11%
Transgenic Mouse
5%
Transgenic Organism
5%
Immunology and Microbiology
Regulatory T Cell
100%
Indoleamine 2,3-dioxygenase
100%
Immunosuppressive Drug
11%
Long Term Survival
11%
T Cell
11%
Immunosuppression
5%
Transgenic Mouse
5%
CD4
5%
Tumor Rejection
5%
Transgenic Organism
5%